skip to Main Content

Starving Pancreatic Cancer Cells of Cysteine May Induce Tumor Ferroptosis

Newsfeed image, light gray text on dark gray background
A new study from Columbia University Irving Medical Center and the Herbert Irving Comprehensive Cancer Center suggests a compound in development for a rare kidney stone disease may have potential against pancreatic cancer.

The compound starves tumors of an amino acid, cysteine, which was found to be critical to the survival of pancreatic cancer cells.The study, conducted in mice with pancreatic cancer, was published online today in the journal Science. Read more . . . 

Back To Top